215 related articles for article (PubMed ID: 30606723)
1. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
[TBL] [Abstract][Full Text] [Related]
2. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.
Orlando G; Law PJ; Cornish AJ; Dobbins SE; Chubb D; Broderick P; Litchfield K; Hariri F; Pastinen T; Osborne CS; Taipale J; Houlston RS
Nat Genet; 2018 Oct; 50(10):1375-1380. PubMed ID: 30224643
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms.
Hoang PH; Dobbins SE; Cornish AJ; Chubb D; Law PJ; Kaiser M; Houlston RS
Leukemia; 2018 Nov; 32(11):2459-2470. PubMed ID: 29654271
[TBL] [Abstract][Full Text] [Related]
4. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
5. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
Wang J; Dayem Ullah AZ; Chelala C
Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
[TBL] [Abstract][Full Text] [Related]
6. CNCDatabase: a database of non-coding cancer drivers.
Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNA mutations in cancer.
Zhou H; Hao X; Zhang P; He S
Wiley Interdiscip Rev RNA; 2023; 14(6):e1812. PubMed ID: 37544928
[TBL] [Abstract][Full Text] [Related]
8. Family-based whole-genome sequencing identifies compound heterozygous protein-coding and noncoding mutations in tetralogy of Fallot.
Wang Y; Jiang T; Tang P; Wu Y; Jiang Z; Dai J; Gu Y; Xu J; Da M; Ma H; Jin G; Mo X; Li Q; Wang X; Hu Z
Gene; 2020 May; 741():144555. PubMed ID: 32165302
[TBL] [Abstract][Full Text] [Related]
9. Cancer regulatory variation.
Hennessey RC; Brown KM
Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
[TBL] [Abstract][Full Text] [Related]
10. Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression.
Leeman-Neill RJ; Song D; Bizarro J; Wacheul L; Rothschild G; Singh S; Yang Y; Sarode AY; Gollapalli K; Wu L; Zhang W; Chen Y; Lauring MC; Whisenant DE; Bhavsar S; Lim J; Swerdlow SH; Bhagat G; Zhao Q; Berchowitz LE; Lafontaine DLJ; Wang J; Basu U
Nat Genet; 2023 Dec; 55(12):2160-2174. PubMed ID: 38049665
[TBL] [Abstract][Full Text] [Related]
11. The role of noncoding mutations in blood cancers.
Rahman S; Mansour MR
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31771951
[TBL] [Abstract][Full Text] [Related]
12. Deep sequencing of 10,000 human genomes.
Telenti A; Pierce LC; Biggs WH; di Iulio J; Wong EH; Fabani MM; Kirkness EF; Moustafa A; Shah N; Xie C; Brewerton SC; Bulsara N; Garner C; Metzker G; Sandoval E; Perkins BA; Och FJ; Turpaz Y; Venter JC
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11901-11906. PubMed ID: 27702888
[TBL] [Abstract][Full Text] [Related]
13. Hidden Genetic Variation in LCA9-Associated Congenital Blindness Explained by 5'UTR Mutations and Copy-Number Variations of NMNAT1.
Coppieters F; Todeschini AL; Fujimaki T; Baert A; De Bruyne M; Van Cauwenbergh C; Verdin H; Bauwens M; Ongenaert M; Kondo M; Meire F; Murakami A; Veitia RA; Leroy BP; De Baere E
Hum Mutat; 2015 Dec; 36(12):1188-96. PubMed ID: 26316326
[TBL] [Abstract][Full Text] [Related]
14. Identification of altered cis-regulatory elements in human disease.
Mathelier A; Shi W; Wasserman WW
Trends Genet; 2015 Feb; 31(2):67-76. PubMed ID: 25637093
[TBL] [Abstract][Full Text] [Related]
15. The human noncoding genome defined by genetic diversity.
di Iulio J; Bartha I; Wong EHM; Yu HC; Lavrenko V; Yang D; Jung I; Hicks MA; Shah N; Kirkness EF; Fabani MM; Biggs WH; Ren B; Venter JC; Telenti A
Nat Genet; 2018 Mar; 50(3):333-337. PubMed ID: 29483654
[TBL] [Abstract][Full Text] [Related]
16. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma.
Kim JH; Kim WS; Park C
Leuk Lymphoma; 2013 Sep; 54(9):2035-40. PubMed ID: 23363221
[TBL] [Abstract][Full Text] [Related]
18. Mutations in Noncoding
El Ghamrasni S; Quevedo R; Hawley J; Mazrooei P; Hanna Y; Cirlan I; Zhu H; Bruce JP; Oldfield LE; Yang SYC; Guilhamon P; Reimand J; Cescon DW; Done SJ; Lupien M; Pugh TJ
Mol Cancer Res; 2022 Jan; 20(1):102-113. PubMed ID: 34556523
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer.
Heyn H
PLoS Genet; 2016 Mar; 12(3):e1005826. PubMed ID: 26938653
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
